|
|
Bristol myers Squibb Company (BMY) |
|
|
|
Bristol Myers Squibb's Yearly Net Income Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Net Income Annual Growth Rates Y/Y▼
|
Annual Net Income Annual Growth Rates Y/Y▼
|
BMY Annual Net Income Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual Net Income Change |
26.71 % |
-9.54 % |
- |
- |
-30.06 % |
Annual Net Income (in millions $) |
$8,040.00 |
$6,345.00 |
$7,014.00 |
$-8,995.00 |
$3,460.00 |
Annual Net Income Growth
Comment |
Bristol Myers Squibb's Annual Net Income for the fiscal year ended 2023, jumped by 26.71% to $8,040.00 millions, from $6,345.00 millions achieved a year ago. Bristol Myers Squibb's growrh rate for Net Income improved from -9.54 % decline in the fiscal year 2022.
Bristol Myers Squibb Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Net Income within Healthcare Sector | Y/Y Net Income Growth % | 2023 Annual Net Income | Pfizer Inc | -93.13 % | $ 2,158.000 millions | Johnson and Johnson | 95.94 % | $ 35,153.000 millions | Biontech Se | -90.14 % | $ 1,041.936 millions | Novartis Ag | 113.57 % | $ 14,854.000 millions | Medtronic Plc | -25.25 % | $ 3,784.000 millions | Regeneron Pharmaceuticals Inc | -8.87 % | $ 3,953.600 millions | Vertex Pharmaceuticals Inc | 8.96 % | $ 3,619.600 millions | Biogen Inc | -60.78 % | $ 1,161.500 millions | Stryker Corp | 34.22 % | $ 3,165.000 millions | Zoetis Inc | 10.85 % | $ 2,340.000 millions | Becton Dickinson And Company | -16.58 % | $ 1,484.000 millions | Takeda Pharmaceutical Company Limited | 30.34 % | $ 2,196.436 millions | Edwards Lifesciences Corporation | -8.05 % | $ 1,399.400 millions | Intuitive Surgical Inc | 35.18 % | $ 1,817.300 millions | Agilent Technologies inc | -1.12 % | $ 1,240.000 millions | Iqvia Holdings Inc | 24.47 % | $ 1,358.000 millions | Quest Diagnostics Inc | -10.54 % | $ 908.000 millions | Fresenius Medical Care Ag | -18.10 % | $ 820.353 millions | Tenet Healthcare Corp | 30.97 % | $ 1,311.000 millions | Organon and Co | 11.56 % | $ 1,023.000 millions | Davita Inc | 22.43 % | $ 956.978 millions | Resmed Inc | 15.15 % | $ 897.556 millions | United Therapeutics Corporation | 35.40 % | $ 984.800 millions | Boston Scientific Corporation | 128.08 % | $ 1,592.000 millions | Idexx Laboratories Inc | 24.44 % | $ 845.042 millions | Icon Plc | 144.76 % | $ 1,236.802 millions | Alcon inc | 190.75 % | $ 974.000 millions | Royalty Pharma Plc | 638.96 % | $ 1,700.088 millions | Ironwood Pharmaceuticals inc | | | |